Haemodynamic monitoring is a vital part of daily practice in anaesthesia and intensive care. Although there is evidence to suggest that goal-directed therapy may improve outcomes in the perioperative period, which haemodynamic targets we should aim at to optimise patient outcomes remain elusive and controversial. This review highlights the pitfalls in commonly used haemodynamic targets, including arterial blood pressure, central venous pressure, cardiac output, central venous oxygen saturation and dynamic haemodynamic indices. Evidence suggests that autoregulation in regional organ circulation may change either due to chronic hypertension or different disease processes such as traumatic brain injury, cerebrovascular ischaemia or haemorrhage; this will influence the preferred blood pressure target. Central venous pressure can be influenced by multiple pathophysiological factors and, unless central venous pressure is very low, it is rarely useful as a predictor for fluid responsiveness. Central venous oxygen saturation can be easily increased by a high arterial oxygen tension, making it useless as a surrogate marker of good cardiac output or systemic oxygen delivery in the presence of hyperoxaemia. Many dynamic haemodynamic indices have been reported to predict fluid responsiveness, but they all have their own limitations. There is also insufficient evidence to support that giving fluid until the patient is no longer fluid responsive can improve patient-centred outcomes. With the exception in the context of preventing contrast-induced nephropathy, large randomised controlled studies suggest that excessive fluid treatment may prolong duration of mechanical ventilation without preventing acute kidney injury in the critically ill.
Haemodynamic monitoring is a vital part of daily practice in anaesthesia and intensive care. The ability to optimise haemodynamics to ensure adequate organ perfusion and improve clinical outcomes is one of the many holy grails in anaesthesia and intensive care. Although there is evidence to suggest that goal-directed therapy may improve outcomes in the perioperative setting 1 , which haemodynamic targets we should aim at to optimise patient outcomes remain elusive and controversial.
Apart from the traditional haemodynamic targets such as blood pressure, urine output, central venous pressure and cardiac output, there are many haemodynamic parameters that are increasingly available to anaesthetists and intensivists, including central venous oxygen saturation and dynamic indices. This narrative review aims to summarise the pitfalls of different haemodynamic targets, and in so doing, assess whether the aim to find a single ideal haemodynamic target for all patients in different perioperative and critical care settings is, in fact, an unrealistic goal.
Arterial blood pressure
Arterial blood pressure is the most common haemodynamic target we use for our patients on a daily basis. Although normal blood pressure for patients at different age groups has been well established, the optimal blood pressure for patients with different pathological conditions remains unclear. While intuition tells us that aiming at a normal blood pressure is a sensible haemodynamic target, we should not assume that bringing a patient's blood pressure to normal range will improve outcomes. This is because many interventions that change blood pressure, either directly or indirectly, can induce harms which may outweigh any potential benefits of getting the blood pressure back to normal. Furthermore, an optimal blood pressure for different individuals may also be different, making the strategy of 'onesize-fits-all' potentially problematic.
Recent studies have focused on whether autoregulation at regional organ perfusion level is preserved, and if so, a normal blood pressure target may not be essential or beneficial. In the setting of septic shock, a recent randomised controlled trial (RCT) showed that a higher mean arterial pressure (MAP) (80 to 85 mmHg) was not associated with a reduction in mortality compared to targeting a lower MAP Anaesth Intensive Care 2016 | 44:1 (60 to 65 mmHg) 2 . Nevertheless, in the subgroup of patients with chronic hypertension in this study, maintaining a higher MAP was associated with a reduced risk of acute kidney injury requiring renal replacement therapy (31.7% versus 42.2%). This suggests that the autoregulation for optimal renal perfusion has shifted rightward or towards a higher level in patients with chronic hypertension. This study also showed that using catecholamines to maintain a higher MAP was associated with an increased risk of atrial fibrillation. Whether clinicians should aim at a higher MAP for patients with chronic hypertension in septic shock would thus depend on whether the benefits of reducing acute kidney injury outweigh the risks of precipitating atrial fibrillation (6.7% versus 2.8%) and possibly coronary ischaemia (acute myocardial infarction 1.8% versus 0.5%). Conversely, a higher MAP (75 to 85 mmHg) is no more effective than a lower MAP (50 to 60 mmHg) during cardiopulmonary bypass in reducing acute kidney injury after on-pump cardiac surgery 3 .
The optimal blood pressure target for patients with brain injury is complicated. Cerebral bloodflow is normally maintained over a range of blood pressures due to autoregulation. It has long been known that cerebral autoregulation can be impaired after different types of brain injury and hence, a certain threshold of cerebral perfusion pressure (CPP) is recommended (e.g. >60 mmHg). Recent evidence suggests that cerebral bloodflow autoregulation can vary substantially between patients after traumatic brain injury. The standard CPP target of >60 mmHg may not be adequate for some, but excessive for others, with a U-shaped curve for neurological outcomes in relation to the duration of CPP being suboptimal 4, 5 . Pressure reactivity index can be assessed by adjusting the CPP and observing its effect on intracranial pressure over time 4, 5 , allowing an optimal CPP to be individualised and appearing more promising. Currently, there is still insufficient evidence to confirm that monitoring intracranial pressure and CPP after traumatic brain injury would improve patient-centred outcomes. For patients with spontaneous intracerebral haemorrhage, pooled results from RCTs suggest that keeping systolic blood pressure below 150 mmHg may reduce the risk of haematoma expansion within the first 24 hours of haemorrhagic stroke and improve neurological outcome compared to keeping systolic blood pressure <180 mmHg 6 . Similar approaches to blood pressure control do not, however, appear to influence neurological outcome for patients with ischaemic stroke 7 . Systemic hypertension occurs in many patients after carotid endarterectomy or carotid stenting, due to denervation or dysfunction of the carotid baroreceptors. In these patients, impaired cerebral autoregulation may fail to adjust to a sudden increase in cerebral blood flow immediately after relieving the carotid arterial obstruction, resulting in cerebral hyperperfusion with cerebral oedema if systemic hypertension is not treated promptly within the first few hours after surgery 8 . For patients who have had recent ischaemic stroke or bilateral critical carotid stenosis before surgery, cerebral hyperperfusion can be transformed into catastrophic intracerebral haemorrhage, and as such, aggressive antihypertensive therapy aiming at systolic blood pressure <140 to 160 mmHg, possibly better with beta-blockers than vasodilators, is advisable for these highrisk patients. The factors that should be considered when using arterial blood pressure as a haemodynamic target are summarised in Table 1 .
Central venous pressure
Central venous pressure (CVP) has been used for many decades as a target to guide fluid therapy. Recent metaanalyses suggested that the utility of CVP as a surrogate marker of preload or fluid responsiveness is overrated 9 . While a very low CVP is likely to suggest a patient's cardiac output may be fluid responsive 10 , a CVP between 5 and 20 mmHg has almost no predictive value. Even changes in CVP with fluid boluses have not been proven to predict fluid responsiveness 9 . This is not surprising given that CVP can be affected by multiple factors other than intravascular volume, including venous resistance, intrathoracic pressure, intraabdominal pressure and pulmonary vascular resistance 11 . Indeed, in patients with right heart dysfunction (e.g. acute pulmonary embolism), use of fluid boluses to increase CVP to a high level may be harmful, as the right heart is very prone to dilate with excessive filling and the left heart can be paradoxically under-filled due to interventricular dependency 12 . Other studies have also shown that CVP has no discriminative value in predicting adequacy of systemic oxygen delivery for patients after major surgery 13 and is not reliable in predicting the size or collapsibility of the superior vena cava 14 . Despite the use of ultrasound technology, serious mechanical complications related to central venous catheterisation can still occur 15 . Perhaps, the potential benefits of CVP monitoring alone may not justify the associated risks of central venous catheterisation, if there are no other indications for central venous catheterisation such as reliable central vascular access for vasoactive medications.
Cardiac output
Cardiac output can be measured continuously by a pulmonary artery catheter, PiCCO® (Philips, Amsterdam, Netherlands) (or other pulse contour) monitor, or oesophageal Doppler so that fluid and inotropes can be titrated to a certain target [16] [17] [18] . It is important to appreciate that cardiac output is a measure of the circulation and not the heart itself. Hence, we should not assume a patient with a relatively normal cardiac index (e.g. 2.5 l/min/m 2 ) will have a normal heart 19 . In fact, it is possible for a dilated and failing heart to generate a stroke volume similar to a hyperdynamic but empty heart, for simple geometric reasons. Furthermore, a low normal cardiac output can also be achieved in the presence of a reduced stroke volume in the presence of tachycardia. With these limitations in mind, the cardiac output measured by different devices should be interpreted in the context of the patient's heart rate and left and right ventricular function as assessed by echocardiography. Although maintaining a relatively normal cardiac output in critical illness makes intuitive sense, whether interventions that are capable of improving cardiac output can improve patient-centred outcomes remains elusive, and likely to vary in different pathological conditions.
Central and mixed venous oxygen saturation (CvO 2 and SvO 2 )
CvO 2 and SvO 2 have been used to reflect the balance between systemic oxygen delivery and consumption. If the systemic oxygen delivery is inadequate relative to the oxygen consumption, oxygen extraction is increased, resulting in a low CvO 2 and SvO 2 . Venous oxygen saturation has been shown to correlate with other haemodynamic parameters, including cardiac output and central venous-arterial carbon dioxide gradient in patients with circulatory failure and after major surgery 20, 21 . Based on the assumption that optimising CvO 2 and SvO 2 may reduce the risk of systemic oxygen debt, multiple RCTs incorporating a treatment algorithm aimed to optimise CvO 2 have been conducted. Surprising to many people, such a treatment algorithm has not been effective in reducing mortality in patients with severe sepsis in multicentre RCTs [22] [23] [24] , despite the use of more intravenous fluid, blood transfusion and use of inotropes or vasopressors associated with the early-goal-directed-therapy (EGDT). The reasons behind why using CvO 2 as a therapeutic target was not effective in reducing mortality remain unclear. The first and foremost criticism of these trials is that patients who were recruited in these RCTs were already adequately resuscitated before the initiation of EGDT, with the mean baseline 25 . Second, the traditional physiology teaching states that arterial oxygen tension (PaO 2 ) contributes very little to the arterial oxygen content and hence, also systemic oxygen delivery. It is then assumed that PaO 2 would not affect the CvO 2 or SvO 2 and hence, PaO 2 is not important when using CvO 2 to guide fluid therapy, transfusion or inotropes. We have to understand that it is the PaO 2 that determines the arterial oxygen saturation (SaO 2 ), and likewise, it is the central or mixed venous oxygen tension that determines the CvO 2 or SvO 2 , respectively. Because the venous oxygen tension normally lies on the steep part of the haemoglobinoxygen dissociation curve, a small change in central and mixed venous oxygen tension can have a substantial effect Table 1 Factors to consider when using blood pressure as a haemodynamic target in the perioperative and critical care setting
1.
Technical issues: optimal damping and no subclavian or femoral artery stenosis proximal to the arterial catheter.
2.
Arterial blood pressure waveform in addition to mean arterial pressure may give some indirect information to the haemodynamic status of the patients (e.g. a low diastolic blood pressure may imply vasodilatation, a small pulse pressure may suggest a small stroke volume, a wide variation in systolic blood pressure or pulse pressure in relation to positive pressure ventilation may suggest hypovolaemia)
3.
Potential benefits should be greater than harms induced by interventions or drugs used to maintain the blood pressure (e.g. atrial fibrillation from catecholamines)
4.
Presence of chronic hypertension may suggest that a higher mean arterial blood pressure for renal perfusion is needed
5.
Recent-onset intracerebral haemorrhage may benefit from a lower systolic blood pressure (<150 mmHg)
6.
Cerebral hyperperfusion syndrome and/or intracerebral haemorrhage after carotid stenting or endarterectomy for critical carotid stenosis may occur if systolic blood pressure is higher than 140 to 160 mmHg immediately after surgery 27 . This result was subsequently confirmed by similar studies and mathematical modelling [28] [29] [30] . Even in patients without obvious extreme hyperoxaemia, PaO 2 remains the most important factor in determining CvO 2 in patients after major surgery 13 . In fact, hyperoxaemia (mean PaO 2 >120 mmHg) was common in patients recruited in the RCT on EGDT 22 , making the algorithm aiming at a high CvO 2 without considering the effect of hyperoxaemia on CvO 2 vulnerable to uncontrolled bias.
Third, the normal value of CvO 2 or SvO 2 in the presence of severe sepsis remains uncertain. This is because systemic shunts due to redistribution of microcirculation bloodflow or mitochondrial dysfunction at the cellular level can both increase CvO 2 or SvO 2 to a supranormal level (>90%) which is associated with an increased mortality 31 . This may also explain why EGDT may be more useful in the elective perioperative setting 1 , where hypovolaemic or cardiogenic shock is more common than sepsis. If CvO 2 or SvO 2 is used to guide haemodynamic therapy, it is important to make sure that PaO 2 is not higher than the bare acceptable range (e.g. <60 to 70mmHg) and hypovolaemia or cardiac failure is the dominant mechanism of circulatory failure. It is best to understand that a low CvO 2 or SvO 2 is very suggestive of inadequate systemic oxygen delivery; but a normal CvO 2 or SvO 2 does not necessarily confirm the septic process is adequately treated in severe sepsis due to presence of systemic shunts. A relatively normal CvO 2 or SvO 2 (and also other haemodynamic parameters for this matter) should not automatically trigger a laissez-faire approach to the management of the patients with severe sepsis; an aggressive source control remains paramount.
Dynamic haemodynamic indices to predict fluid responsiveness
A wide range of dynamic haemodynamic indices, including pulse pressure or stroke volume variation, plethysmographic variability index, and respiratory variation of the diameter of the inferior or superior vena cava or jugular vein, have emerged in the past decade. Dynamic indices have theoretical advantages over static indices such as central venous pressure, pulmonary capillary wedge pressure or left ventricular diastolic volume because they reflect how venous filling or stroke volume changes with changes in intrathoracic pressure. However, as more and more studies about dynamic haemodynamic indices have emerged, the limitations of these indices have also become apparent.
Firstly, the predictive ability of these indices may be heavily influenced by the magnitude of the ventilating pressure or tidal volume used and whether the patient is spontaneously breathing 32, 33 . A lack of respiratory variations in inferior vena cava diameter, central venous pressure or even pulse volume is clinically more useful in telling us that the patient is unlikely to be fluid responsive [34] [35] [36] . Conversely, presence of respiratory variations in these dynamic indices does not guarantee the patient is fluid responsive, especially when there is a large variation in intrathoracic pressure during the respiratory cycle. As such, these dynamic indices may be best labelled as markers of 'fluid unresponsiveness' rather than 'fluid responsiveness'. Secondly, because positive intrathoracic pressure has a different effect on stroke volume in patients with and without left ventricular failure, pulse pressure variation is not useful in predicting fluid responsiveness in patients with left ventricular failure 37 . Thirdly, pulse pressure variation or plethysmographic variability index can be affected by cardiac arrhythmias, or peripheral vasoconstriction from shock or use of vasopressor 38 . Fourthly, the performance of these dynamic indices appears to be limited in paediatric patients 33, 39 . Finally, there is insufficient evidence to suggest that optimising fluid responsiveness can improve clinical outcomes 40 . We should not assume that any patients who are fluid responsive should receive more fluid until they are no longer fluid responsive 41 . In addition, some types of intravenous fluid may also have adverse effects on the coagulation or renal system 42, 43 , especially if a large amount of such fluid is used. With the exception in the context of preventing contrast-induced nephropathy 44 , evidence suggests that excessive fluid treatment may prolong duration of mechanical ventilation without preventing acute kidney injury in critically ill and surgical patients [45] [46] [47] . The limitations of using central venous pressure and dynamic indices to guide fluid therapy are summarised in Table 2 .
Conclusion
There are many potential useful haemodynamic targets we can use for patients undergoing major surgery and in the ICU. Unfortunately, most of these haemodynamic targets are heavily context-dependent and may change over time, even for the same patient. Using the same haemodynamic target to treat patients with different acute diseases and chronic comorbidities is unlikely to achieve the best outcomes for all. Knowing the pitfalls of different haemodynamic targets does not suggest that we should abandon using these targets for our patients. It should be noted that circulatory failure or shock is not a disease itself, but a complication of an underlying pathological process. In this context, haemodynamic response to medical treatments should be considered as a part of a feedback loop to confirm whether the correct diagnosis is made, and appropriate source control and therapy have been delivered (Figure 1) .
When clinical signs of the patients do not fit together (e.g. 'septic shock' from pneumonia without significant oxygen requirement, 'septic shock' with a relatively high central venous pressure without too much prior fluid therapy), or patients who fail to respond to initial resuscitation or require continued escalation of the doses of vasopressor, then it is mandatory to obtain more information from the patients. This may include, but is not limited to, further biochemical tests (e.g. lactate, troponin, brain-natriuretic-peptide), radiological imaging and echocardiography. Exclusion of obstructive shock, such as cardiac tamponade or acute pulmonary embolism, is particularly important. Different underlying diseases and context of the patients will invariably dictate what haemodynamic targets are more likely to be useful. Practically, a combination of clinical examination, biochemistry, radiological imaging and echocardiographic assessment will be pivotal in addition to targeting fluid and inotropic therapy to a certain set of haemodynamic targets in difficult cases. The potential harms of all interventions, including commonly used intravenous fluids and drugs, used to achieve the haemodynamic targets should also be carefully considered. A single ideal haemodynamic target for all patients in different perioperative and critical care settings may exist, we just have not found it yet. Until then, using multiple haemodynamic targets, tailored to a patient's underlying pathological condition, to guide haemodynamic support appears to be the best option we have.
